AstraZeneca's COVID vaccine is 79% effective, new U.S. study finds

AstraZeneca's coronavirus vaccine provides strong protection against symptomatic cases and completely prevents severe disease and hospitalizations, according to a new late-stage study conducted in the United States, the company announced Monday.